Coexistence of TERT C228T mutation and MALAT1 dysregulation in primary glioblastoma: new prognostic and therapeutic targets

Conclusions: Our findings highlight that the presence of TERT C228T mutation and expression of MALAT1 can be used as primary targets during the follow-up of primary GB patients and in the development of new treatment strategies.PMID:34210246 | DOI:10.1080/01616412.2021.1948738
Source: Neurological Research - Category: Neurology Authors: Source Type: research